novel formulation of extended-release (ER) methylphenidate hydrochloride that utilizes multiple layers of coatings on beads for encapsulation into hard gelatin capsule shells (Aptensio®, MPH-MLR) was evaluated to…
this study, a novel approach is proposed for determination of methylphenidate in biological fluids. In this method molecularly imprinted solid-phase extraction (MISPE), as the sample extraction technique, combined with…
novel formulation of extended-release (ER) methylphenidate hydrochloride that utlizes multiple layers of coatings on microbeads for encapsulation into hard gelatin capsule shells (AptensioâÂ?¢, MPH-MLR) was evaluated to…
their use in the acute setting is limited. Here, we describe a case where methylphenidate was used in a patient with coma after grade III diffuse axonal injury ... among others. His GCS mostly varied from 3 to 4. He was…
Methylphenidate (Ritalin), a stimulant medication treats attention deficit hyperactivity disorder (ADHD) and narcolepsy. Methylphenidate is a central nervous system (CNS) stimulant of the phenethylamine and piperidine…
were also surveyed about their attitudes towards the use of methylphenidate (MPH) and their personal use (both with and without prescription). A sample of 312 students was taken from ... educated about the importance of…
problems in the world especially in Asia. Objective: To evaluate the efficacy of adding methylphenidate 30 mg daily to the treatment of methamphetamine withdrawal craving. Method: To study double blindly ... single…
robust and rugged reverse phase high performance liquid chromatographic (RPHPLC) method for analysis of Methylphenidate hydrochloride (MPH) and its Impurities in a tablet dosage form have been developed and validated…
ADHD) behaviour and co-morbid physical/psychiatric symptoms, compared to Placebo and the medicine Methylphenidate (MPH) and to assess its tolerability. Behaviour (measured by the ADHD-Rating Scale (ADHD ... French…
Methylphenidate remains the first choice treatment for attention deficit hyperactivity disorder (ADHD), but comorbid forms with Disruptive Behaviour Disorders (DBD) are undertreated. Methylphenidate adjunction is…
Psychostimulant medications, such as methylphenidate (MPH) have become mainstay treatments for Attention Deficit Hyperactivity Disorder (ADHD) symptoms, such as hyperactivity, impulsivity and inattention in children…
determine if a literature-sourced physiological model for immediate-release (IR) methylphenidate (MPH), with addition of parameters for extended-release (ER) absorption can be adapted for NONMEM analysis to describe…
behavioral modifications and adjustment of the medications. Interestingly, the addition of low dose methylphenidate not only resulted in successful resolution of EDS without changing the only effective regimen but also…
disorders in children is ADHD (Attention Deficit Hyperactivity Disorder), which is treated extensively by Methylphenidate. This study investigates the assessment of the effects of methylphenidate on histopathologic and…
ADHD and conduct disorder. In treatment of ADHD most common used pharmacological agent is methylphenidate. Atypical antipsychotics (e.g. risperidone, aripiprazole, olanzapine) can be added to treatment in some cases…
Methylphenidate (MPH) prescription rates have been increasing steadily in the last few years, and diversion of the drug is becoming an issue, especially among young people. As is commonly known ... with regards to MPH…
admitted to an emergency department with acute dystonia following the ingestion of methylphenidate, a stimulant pharmalogical agent used for the treatment for attention-deficit hyperactivity disorder. In conclusion…
sampling versus optimal sampling in Bioequivalence (BE) studies for an Extended-Release (ER) oral Methylphenidate (MP) tablet with complex absorption Concerta®. Methods: For approval of generic versions of Concerta
Aptensio XR® is an Extended-Release (ER) Methylphenidate (MPH) capsule drug product, approved for use in patients 6 years and older. Absorption of Aptensio XR® in children has been characterized
Aptensio XR® is an Extended-Release (ER) Methylphenidate (MPH) capsule drug product, approved for use in patients 6 years and above. Clinical studies have been conducted in adults
studies on saccadic eye movements (SEMs) in adults with attention-deficit/ hyperactivity disorder (ADHD). Methylphenidate (MPH) is an effective treatment for ADHD symptoms. We therefore evaluated oculomotor performances…
ABSTRACT Objective: We aimed to clarify the validity of fNIRS measurement for assessing the methylphenidate (MPH) induced neuropharmacological effect in medication-naïve children with attention deficit hyperactivity…
Methylphenidate (MPD) is the most regularly prescribed psychostimulant for patients with attention-deficit hyperactivity disorder (ADHD). It has also been used by general population, especially college students, without…
psychostimulant methylphenidate (MPD) is the pharmacotherapy of choice for the treatment of attention deficit disorder (ADD), attention deficit hyperactivity disorder (ADHD), narcolepsy, dementia, chronic fatigue and…
deficit/hyperactivity disorder (ADHD) is among the most frequent neurodevelopmental disorders. Atomoxetine (ATX) and methylphenidate (MPH) have been recommended as primary medication choices to treat inhibition- and…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.